SP Scientific Signs License Agreement with Praxair

Praxair, Inc.

has announced that SP Scientific has signed a license agreement to utilize Praxair's ControLyo nucleation on-demand technology, which provides pharmaceutical and biotechnology companies with precise control over the freeze-drying process for drug developmental efforts. Praxair's breakthrough technology was developed to specifically control the freezing step of lyophilization, a method of drying pharmaceuticals whereby the material is frozen and then warmed in a vacuum so that the ice vaporizes. Until now, this freezing step of lyophilization was uncontrolled due to the random nature of the nucleation or crystal-forming process.